CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-29 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 | ||
| 2021-10-29 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 | ||
| 2021-10-29 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 | ||
| 2021-10-29 | Omega Fund V, L.P. 10% owner | Sale | −45,000 | $9.27 | $417K | 27,152,376 |
| 2021-10-28 | Omega Fund V, L.P. 10% owner | Sale | −1,015,000 | $9.60 | $9.7M | 27,197,376 |
| 2021-07-31 | NODELMAN OLEG Director | Purchase | +56,598 | $8.64 | $489K | 7,198,407 |
| 2021-07-31 | NODELMAN OLEG Director | Sale | −56,598 | $8.64 | $489K | 1,147,483 |
| 2021-06-01 | Hanley David C. Chief Technical Operations | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-06-01 | Hanley David C. Chief Technical Operations | Grant or award · Stock Option (Right to Buy) | +187,500 | 187,500 | ||
| 2021-04-13 | NODELMAN OLEG Director | Purchase | +27,534 | $10.27 | $283K | 6,990,265 |
| 2021-04-13 | NODELMAN OLEG Director | Purchase | +3,966 | $10.27 | $41K | 1,355,625 |
| 2021-04-12 | NODELMAN OLEG Director | Purchase | +116,255 | $9.49 | $1.1M | 6,962,731 |
| 2021-04-12 | NODELMAN OLEG Director | Purchase | +16,745 | $9.49 | $159K | 1,351,659 |
| 2021-04-09 | NODELMAN OLEG Director | Purchase | +262,230 | $10.03 | $2.6M | 6,846,476 |
| 2021-04-09 | NODELMAN OLEG Director | Purchase | +37,770 | $10.03 | $379K | 1,334,914 |
| 2021-03-31 | NODELMAN OLEG Director | Purchase | +151,544 | $10.45 | $1.6M | 6,735,790 |
| 2021-03-31 | NODELMAN OLEG Director | Sale | +151,544 | $10.45 | $1.6M | 1,145,600 |
| 2021-03-30 | Bazemore Robert B Director | Purchase | +5,000 | $9.98 | $50K | 5,000 |
| 2021-03-09 | Hung David President and CEO | Grant or award · Stock Option (Right to Buy) | +165,465 | 165,465 | ||
| 2021-03-09 | Hung David President and CEO | Grant or award · Stock Option (Right to Buy) | +224,760 | 224,760 |
Page 12 of 15 · 291 trades